{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T02:35:50Z","timestamp":1790994950393,"version":"4.1.0"},"reference-count":65,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2013,2,25]],"date-time":"2013-02-25T00:00:00Z","timestamp":1361750400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["bpspubs.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["British J Pharmacology"],"published-print":{"date-parts":[[2013,3]]},"abstract":"<jats:sec><jats:title>Background and Purpose<\/jats:title><jats:p>To evaluate the ability of cannabidiolic acid (<jats:styled-content style=\"fixed-case\">CBDA<\/jats:styled-content>) to reduce nausea and vomiting and enhance 5\u2010<jats:styled-content style=\"fixed-case\">HT<jats:sub>1A<\/jats:sub><\/jats:styled-content> receptor activation in animal models.<\/jats:p><\/jats:sec><jats:sec><jats:title>Experimental Approach<\/jats:title><jats:p>We investigated the effect of <jats:styled-content style=\"fixed-case\">CBDA<\/jats:styled-content> on (i) lithium chloride (<jats:styled-content style=\"fixed-case\">LiCl<\/jats:styled-content>)\u2010induced conditioned gaping to a flavour (nausea\u2010induced behaviour) or a context (model of anticipatory nausea) in rats; (ii) saccharin palatability in rats; (iii) motion\u2010, <jats:styled-content style=\"fixed-case\">LiCl<\/jats:styled-content>\u2010 or cisplatin\u2010induced vomiting in house musk shrews (<jats:italic><jats:styled-content style=\"fixed-case\">S<\/jats:styled-content>uncus murinus<\/jats:italic>); and (iv) rat brainstem 5\u2010<jats:styled-content style=\"fixed-case\">HT<jats:sub>1A<\/jats:sub><\/jats:styled-content> receptor activation by 8\u2010hydroxy\u20102\u2010(di\u2010<jats:italic>n<\/jats:italic>\u2010propylamino)tetralin (8\u2010<jats:styled-content style=\"fixed-case\">OH\u2010DPAT<\/jats:styled-content>) and mouse whole brain <jats:styled-content style=\"fixed-case\">CB<\/jats:styled-content><jats:sub>1<\/jats:sub> receptor activation by <jats:styled-content style=\"fixed-case\">CP<\/jats:styled-content>55940, using [<jats:sup>35<\/jats:sup><jats:styled-content style=\"fixed-case\">S<\/jats:styled-content>]<jats:styled-content style=\"fixed-case\">GTP<\/jats:styled-content>\u03b3<jats:styled-content style=\"fixed-case\">S<\/jats:styled-content>\u2010binding assays.<\/jats:p><\/jats:sec><jats:sec><jats:title>Key Results<\/jats:title><jats:p>In shrews, <jats:styled-content style=\"fixed-case\">CBDA<\/jats:styled-content> (0.1 and\/or 0.5\u2009mg\u00b7kg<jats:sup>\u22121<\/jats:sup> i.p.) reduced toxin\u2010 and motion\u2010induced vomiting, and increased the onset latency of the first motion\u2010induced emetic episode. In rats, <jats:styled-content style=\"fixed-case\">CBDA<\/jats:styled-content> (0.01 and 0.1\u2009mg\u00b7kg<jats:sup>\u22121<\/jats:sup> i.p.) suppressed <jats:styled-content style=\"fixed-case\">LiCl<\/jats:styled-content>\u2010 and context\u2010induced conditioned gaping, effects that were blocked by the 5\u2010<jats:styled-content style=\"fixed-case\">HT<jats:sub>1A<\/jats:sub><\/jats:styled-content> receptor antagonist, <jats:styled-content style=\"fixed-case\">WAY<\/jats:styled-content>100635 (0.1\u2009mg\u00b7kg<jats:sup>\u22121<\/jats:sup> i.p.), and, at 0.01\u2009mg\u00b7kg<jats:sup>\u22121<\/jats:sup> i.p., enhanced saccharin palatability. C<jats:styled-content style=\"fixed-case\">BDA<\/jats:styled-content>\u2010induced suppression of <jats:styled-content style=\"fixed-case\">LiCl<\/jats:styled-content>\u2010induced conditioned gaping was unaffected by the <jats:styled-content style=\"fixed-case\">CB<\/jats:styled-content><jats:sub>1<\/jats:sub> receptor antagonist, <jats:styled-content style=\"fixed-case\">SR141716A<\/jats:styled-content> (1\u2009mg\u00b7kg<jats:sup>\u22121<\/jats:sup> i.p.). <jats:italic>In vitro<\/jats:italic>, <jats:styled-content style=\"fixed-case\">CBDA<\/jats:styled-content> (0.1\u2013100\u2009<jats:styled-content style=\"fixed-case\">nM<\/jats:styled-content>) increased the <jats:italic><jats:styled-content style=\"fixed-case\">E<\/jats:styled-content><\/jats:italic><jats:sub>max<\/jats:sub> of 8\u2010<jats:styled-content style=\"fixed-case\">OH\u2010DPAT<\/jats:styled-content>.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions and Implications<\/jats:title><jats:p>Compared with cannabidiol, <jats:styled-content style=\"fixed-case\">CBDA<\/jats:styled-content> displays significantly greater potency at inhibiting vomiting in shrews and nausea in rats, and at enhancing 5\u2010<jats:styled-content style=\"fixed-case\">HT<jats:sub>1A<\/jats:sub><\/jats:styled-content> receptor activation, an action that accounts for its ability to attenuate conditioned gaping in rats. Consequently, <jats:styled-content style=\"fixed-case\">CBDA<\/jats:styled-content> shows promise as a treatment for nausea and vomiting, including anticipatory nausea for which no specific therapy is currently available.<\/jats:p><\/jats:sec>","DOI":"10.1111\/bph.12043","type":"journal-article","created":{"date-parts":[[2012,11,2]],"date-time":"2012-11-02T11:37:34Z","timestamp":1351856254000},"page":"1456-1470","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":149,"title":["Cannabidiolic acid prevents vomiting in <i><scp>S<\/scp>uncus murinus<\/i> and nausea\u2010induced behaviour in rats by enhancing 5\u2010<scp>HT<sub>1A<\/sub><\/scp> receptor activation"],"prefix":"10.1111","volume":"168","author":[{"given":"D","family":"Bolognini","sequence":"first","affiliation":[{"name":"Institute of Medical Sciences University of Aberdeen  Aberdeen UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"EM","family":"Rock","sequence":"additional","affiliation":[{"name":"Department of Psychology and Neuroscience Graduate Program University of Guelph  Guelph ON Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"NL","family":"Cluny","sequence":"additional","affiliation":[{"name":"Department of Physiology and Pharmacology University of Calgary  Calgary AB Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MG","family":"Cascio","sequence":"additional","affiliation":[{"name":"Institute of Medical Sciences University of Aberdeen  Aberdeen UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CL","family":"Limebeer","sequence":"additional","affiliation":[{"name":"Department of Psychology and Neuroscience Graduate Program University of Guelph  Guelph ON Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Duncan","sequence":"additional","affiliation":[{"name":"Sovereign House GW Research Ltd  Cambridge UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CG","family":"Stott","sequence":"additional","affiliation":[{"name":"Sovereign House GW Research Ltd  Cambridge UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"FA","family":"Javid","sequence":"additional","affiliation":[{"name":"Division of Pharmacy and Pharmaceutical Sciences School of Applied Sciences University of Huddersfield  Huddersfield UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LA","family":"Parker","sequence":"additional","affiliation":[{"name":"Department of Psychology and Neuroscience Graduate Program University of Guelph  Guelph ON Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RG","family":"Pertwee","sequence":"additional","affiliation":[{"name":"Institute of Medical Sciences University of Aberdeen  Aberdeen UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,2,25]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M111.296020"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7525-1-46"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1997.507"},{"key":"e_1_2_8_5_1","unstructured":"BologniniD RockEM CascioMG ParkerL PertweeRG(2012).Cannabidiolic acid behaves as a highly potent enhancer of 5\u2010HT1Areceptor activation bothin vitroandin vivo.22nd Annual Symposium of the Cannabinoids. International Cannabinoid Research Society p.43."},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-008-1168-x"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(73)90196-2"},{"key":"e_1_2_8_8_1","first-page":"527","article-title":"Visually\u2010induced sickness in normal and bilaterally labyrinthine\u2010defective subjects","volume":"62","author":"Cheung BS","year":"1991","journal-title":"Aviat Space Environ Med"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-7843.2008.00253.x"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12272-011-0913-6"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1097\/00001756-199905140-00030"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.90952.2008"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.107.134809"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2010.01166.x"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2010.03743.x"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365\u20102125.2012.04341.x"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejon.2004.03.006"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-010-2036-z"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.663655"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(78)90568-1"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11408"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autneu.2006.09.005"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.physbeh.2005.08.033"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2006.11.018"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1177\/000348946207100201"},{"key":"e_1_2_8_26_1","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3233\/VES-1999-9202","article-title":"Importance of the vestibular system in visually induced nausea and self\u2010vection","volume":"9","author":"Johnson WH","year":"1999","journal-title":"J Vestib Res"},{"key":"e_1_2_8_27_1","unstructured":"KennedyRS GraybielA McDonoughRC BeckwithFD(1965).Symptomatology under storm conditions in the North Atlantic in control subjects and in persons with bilateral labyrinthine defects.NSAM\u2010928. Res Rep US Nav Sch Aviat Med:1\u201310."},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2010.00872.x"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-003-1739-9"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.1999.277.3.G642"},{"key":"e_1_2_8_31_1","first-page":"1111","article-title":"The effects of serotonin (5\u2010HT3) receptor antagonists on gastric tachyarrhythmia and the symptoms of motion sickness","volume":"71","author":"Levine ME","year":"2000","journal-title":"Aviat Space Environ Med"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.physbeh.2006.04.014"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2007.08.024"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2010.00885.x"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2010.01063.x"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000421-199504000-00017"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2010.00873.x"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/0040-4020(65)80064-3"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1185\/030079907X167525"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.0000163083.59201.34"},{"key":"e_1_2_8_41_1","doi-asserted-by":"publisher","DOI":"10.1139\/y64-089"},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.1007\/s005200050161"},{"key":"e_1_2_8_43_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006842-198001000-00004"},{"key":"e_1_2_8_44_1","doi-asserted-by":"publisher","DOI":"10.1037\/0735-7044.117.1.105"},{"key":"e_1_2_8_45_1","doi-asserted-by":"publisher","DOI":"10.3758\/BF03195979"},{"key":"e_1_2_8_46_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-0-387-74349-3_13"},{"key":"e_1_2_8_47_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-002-1329-2"},{"key":"e_1_2_8_48_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-003-1571-2"},{"key":"e_1_2_8_49_1","doi-asserted-by":"publisher","DOI":"10.1037\/a0012531"},{"key":"e_1_2_8_50_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0707442"},{"key":"e_1_2_8_51_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11433"},{"key":"e_1_2_8_52_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1556-4029.2007.00603.x"},{"key":"e_1_2_8_53_1","doi-asserted-by":"publisher","DOI":"10.1177\/014107687807101109"},{"key":"e_1_2_8_54_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-007-0970-1"},{"key":"e_1_2_8_55_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-010-2157-4"},{"key":"e_1_2_8_56_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2011.01621.x"},{"key":"e_1_2_8_57_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0702836"},{"key":"e_1_2_8_58_1","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.34.774"},{"key":"e_1_2_8_59_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1989.tb05345.x"},{"key":"e_1_2_8_60_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.108.020909"},{"key":"e_1_2_8_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2004.01.023"},{"key":"e_1_2_8_62_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0706414"},{"key":"e_1_2_8_63_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0707133"},{"key":"e_1_2_8_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0166-4328(02)00370-4"},{"key":"e_1_2_8_65_1","doi-asserted-by":"publisher","DOI":"10.1002\/lary.1986.96.11.1221"},{"key":"e_1_2_8_66_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2009.00521.x"}],"container-title":["British Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbph.12043","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bph.12043","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T21:04:39Z","timestamp":1697403879000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/bph.12043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,25]]},"references-count":65,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["10.1111\/bph.12043"],"URL":"https:\/\/doi.org\/10.1111\/bph.12043","archive":["Portico"],"relation":{},"ISSN":["0007-1188","1476-5381"],"issn-type":[{"value":"0007-1188","type":"print"},{"value":"1476-5381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,25]]},"assertion":[{"value":"2012-07-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2012-10-12","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2013-02-25","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}